US 6403771
Method and means for site directed therapy
expired A61KA61K51/1045A61K51/1093
Quick answer
US patent 6403771 (Method and means for site directed therapy) held by Actinium Phamaceuticals, Inc. expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K51/1045, A61K51/1093